Wounded Roche confirms appeal on Igen ruling
This article was originally published in Clinica
Executive Summary
Roche Diagnostics has confirmed that it will appeal the decision of the US District Court of Maryland, which has ruled against the Swiss company for breaching licensing agreements relating to Igen's Origen Elecsys electrochemiluminesence technology. The judge in the case this week ruled on post-trial motions, and confirmed the court's earlier ruling that Roche must pay $505 million in punitive and compensatory damages and grant to Igen certain rights to product improvements made by Roche.